Single-Use Technologies—A Contract Biomanufacturer's Perspective - Disposable technology presents an attractive opportunity for CMOs to cut down production costs. - BioPharm International

ADVERTISEMENT

Single-Use Technologies—A Contract Biomanufacturer's Perspective
Disposable technology presents an attractive opportunity for CMOs to cut down production costs.


BioPharm International Supplements


2. Mintz CS. Developing and managing successful bio-outsourcing relationships. D&MD Publications; 2006 Mar;3:Chapter 3–1.

3. High Tech Business Decisions. Biopharmaceutical contract manufacturing—quality, capacities, and emerging technologies. 2007; Chapter 5–71.

4. Waele KD, Vandermarliere M, Broekhoven AV, Vandiest R, and Pendlebury D. A novel single-use mixing system for buffer preparation. Bioprocess Int. 2007 May (5) Supp 4:56–61.

5. Lee, J. Case studies of culture scale-up of production cells grown in disposable-bag bioreactors. A presentation at IBC's 2nd international biopharmaceutical manufacturing & development summit, Dec 6–7, 2006; Orlando, FL.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here